# Phase 3 Heart Failure trials recruiting: 50 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 50 trials in phase 3 for Heart Failure that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 Heart Failure trials: 50 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/heart-failure

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 50
- Recruiting or not yet: 50
- Read on: November 19, 2026

## Trials

The 25 newest of 50, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946107 | BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic Cardiomyopathy | Braveheart Bio, Inc. | Phase 3 | Not yet recruiting | Cardiomyopathy, Hypertrophic Non-Obstructive | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946107) |
| November 6, 2026 | NCT07922863 | MUTTON-HF Pilot Expansion | University of Pennsylvania | Phase 3 | Not yet recruiting | Heart Failure | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922863) |
| September 14, 2026 | NCT07817186 | Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT | Carelon Research | Phase 3 | Not yet recruiting | HCM, Noonan Syndrome and Other Rasopathy, Heart Failure (Pediatric) | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817186) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| July 31, 2026 | NCT07738276 | Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart... | Shahid Beheshti University of Medical Sciences | Phase 3 | Not yet recruiting | Heart Failure and Reduced Ejection Fraction, Obesity & Overweight, Tirzepatide | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738276) |
| July 30, 2026 | NCT07737964 | ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms. | University Hospital, Montpellier | Phase 3 | Not yet recruiting | Heart Failure | 366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737964) |
| July 7, 2026 | NCT07687186 | Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre | Tasly Pharmaceutical Group Co., Ltd | Phase 3 | Recruiting | Heart Failure | 636 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687186) |
| May 19, 2026 | NCT07596329 | Outpatient Hypertonic Saline and Loop Diuretic Combination Therapy in Cardiorenal | University of Monastir | Phase 3 | Not yet recruiting | Heart Failure, Renal Disease, Chronic | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07596329) |
| May 6, 2026 | NCT07569640 | HFrEF Polypill in Sri Lanka RCT | Washington University School of Medicine | Phase 3 | Recruiting | Heart Failure With Reduced Ejection Fraction | 1,672 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569640) |
| May 5, 2026 | NCT07567001 | A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Heart Failure | 5,610 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567001) |
| April 22, 2026 | NCT07543562 | Selenium Intervention Registry Randomized Trial in Heart Failure | Skane University Hospital | Phase 3 | Recruiting | Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction, Heart... | 4,326 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543562) |
| March 27, 2026 | NCT07496372 | A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced... | HELP Therapeutics Co., Ltd. | Phase 3 | Recruiting | Heart Failure | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07496372) |
| March 13, 2026 | NCT07471139 | SWITCH: Apixaban vs Vitamin K in HM3 | Columbia University | Phase 3 | Recruiting | LVAD (Left Ventricular Assist Device) Thrombosis, Heart Failure, Bleeding, Thrombosis; Artery, Stroke, Heart Transplant | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07471139) |
| December 8, 2025 | NCT07270367 | Finerenone and Cardiac Remodeling | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Heart Failure | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270367) |
| November 20, 2025 | NCT07238452 | Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure | University of British Columbia | Phase 3 | Not yet recruiting | Heart Failure With Reduced Ejection Fraction, Atrial Fibrillation (AF) | 1,050 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07238452) |
| November 18, 2025 | NCT07234422 | The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of... | Netherlands Heart Institute | Phase 3 | Recruiting | Heart Failure | 1,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07234422) |
| September 25, 2025 | NCT07192952 | A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young... | Bayer | Phase 3 | Recruiting | Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | 117 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07192952) |
| September 23, 2025 | NCT07188805 | A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to... | Bayer | Phase 3 | Recruiting | Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07188805) |
| July 29, 2025 | NCT07090343 | Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement | Leiden University Medical Center | Phase 3 | Not yet recruiting | Aortic Stenosis, Heart Failure | 826 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07090343) |
| June 25, 2025 | NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity | Amgen | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity | 5,056 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07037459) |
| June 17, 2025 | NCT07025629 | Dapagliflozin for Cardio-renal Protection After ICU Discharge | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | Heart Failure and Chronic Kidney Disease Post-ICU | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07025629) |
| June 12, 2025 | NCT07018297 | Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure | University of Texas Southwestern Medical Center | Phase 3 | Not yet recruiting | Heart Failure, Acute Decompensated Heart Failure | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07018297) |
| June 6, 2025 | NCT07008365 | The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure | Instituto de Investigación Sanitaria Aragón | Phase 3 | Recruiting | Acute Heart Failure, Congestive Heart Failure, Intraabdominal Hypertension, Cardio-Renal Syndrome | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07008365) |
| April 27, 2025 | NCT06946095 | Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction | Beijing Anzhen Hospital | Phase 3 | Not yet recruiting | Heart Failure | 246 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946095) |
| April 20, 2025 | NCT06935370 | A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping... | Boehringer Ingelheim | Phase 3 | Recruiting | Heart Failure | 4,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06935370) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Colorado Prevention Center | 3 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 2 |
| [Bayer](https://specstream.ai/data/clinical-trials/company/bayer) | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| University of Texas Southwestern Medical Center | 2 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 2 |
| Hospital de Clinicas de Porto Alegre | 1 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 1 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 1 |
| [Cytokinetics](https://specstream.ai/data/clinical-trials/company/cytokinetics) | 1 |
| John Paul II Hospital, Krakow | 1 |
| University Hospital, Montpellier | 1 |
| Shahid Beheshti University of Medical Sciences | 1 |
| Washington University School of Medicine | 1 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 1 |
| Central Hospital, Nancy, France | 1 |
| Steno Diabetes Center Copenhagen | 1 |
| HELP Therapeutics Co., Ltd. | 1 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 1 |
| Università Vita-Salute San Raffaele | 1 |
| [Tasly Pharmaceutical Group Co., Ltd](https://specstream.ai/data/clinical-trials/company/tasly-pharmaceutical-group-co-ltd) | 1 |
| Beijing Anzhen Hospital | 1 |
| Instituto de Investigación Sanitaria Aragón | 1 |
| University of Monastir | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 18 |
| Spain | 16 |
| Canada | 15 |
| Italy | 14 |
| Poland | 14 |
| United Kingdom | 14 |
| Brazil | 13 |
| China | 12 |
| Germany | 12 |
| Greece | 12 |
| Argentina | 11 |
| Czechia | 11 |
| France | 11 |
| Taiwan | 11 |
| Hungary | 10 |
| Netherlands | 10 |
| Turkey (Türkiye) | 10 |
| Bulgaria | 9 |
| Mexico | 9 |
| South Korea | 9 |
| Japan | 7 |
| India | 7 |
| Australia | 6 |
| Austria | 6 |
| Belgium | 6 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B mining companies in the United States](https://specstream.ai/data/businesses/b2b-mining-companies/united-states)
- [Fireplace services in the United States](https://specstream.ai/data/businesses/fireplace-services/united-states)
- [Paving contractors in the United States](https://specstream.ai/data/businesses/paving-contractors/united-states)
- [Wholesalers in the United States](https://specstream.ai/data/businesses/wholesalers/united-states)
- [Distilleries in the United States](https://specstream.ai/data/businesses/distilleries/united-states)
- [Masonry and concrete contractors in the United States](https://specstream.ai/data/businesses/masonry-and-concrete-contractors/united-states)
